New CT scoring aims to better detect smell loss in allergy patients
NCT ID NCT07380945
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test a new way to score CT scans to see how well it measures smell loss in people with central compartment atopic disease (CCAD), a type of nasal allergy. Researchers will compare the new scoring system to the traditional one in 120 participants. The goal is to improve diagnosis and understanding of smell problems in these patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to measure smell loss in CCAD patients using CT scans.
- What could go wrong
- This is an early observational study, not a treatment trial. The new scoring system may not prove better than existing methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL COMPARTMENT ATOPIC DISEASE (CCAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Otolaryngology Head and Neck Surgery, Peking University Third Hospital
Beijing, People's Republic of China, 10019, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple antiseptic rinse improve sinus surgery recovery?
- Melatonin may calm nerves before sinus surgery – study finds optimal dose
- New sinus test could change how we treat chronic sinusitis
- Sinus surgery showdown: crushing vs cutting for a common nose problem
- Sinusitis secrets: could a salt channel be the culprit?
- New antibody injection aims to tame stubborn sinusitis